NRAS and melanoma: Interestingly, AZD7545 had no effect on keratinocytes (HaCaT) and normal fibroblasts, cell types which constitute the cutaneous microenvironment of melanoma tumors (data not shown), indicating selective effects on BRAF/NRAS-mutated or resistant cancer cells.